YUANBAO INC -ADR (YB) Fundamental Analysis & Valuation

NASDAQ:YBUS9879101064

Current stock price

16.99 USD
-0.32 (-1.85%)
Last:

This YB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. YB Profitability Analysis

1.1 Basic Checks

  • YB had positive earnings in the past year.
YB Yearly Net Income VS EBIT VS OCF VS FCFYB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 500M 1B

1.2 Ratios

  • YB has a better Return On Assets (43.78%) than 100.00% of its industry peers.
  • The Return On Equity of YB (62.30%) is better than 100.00% of its industry peers.
  • With an excellent Return On Invested Capital value of 31.79%, YB belongs to the best of the industry, outperforming 99.32% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for YB is significantly above the industry average of 9.34%.
  • The 3 year average ROIC (17.77%) for YB is below the current ROIC(31.79%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 43.78%
ROE 62.3%
ROIC 31.79%
ROA(3y)-15.55%
ROA(5y)N/A
ROE(3y)-30.13%
ROE(5y)N/A
ROIC(3y)17.77%
ROIC(5y)N/A
YB Yearly ROA, ROE, ROICYB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

  • YB has a Profit Margin of 45.67%. This is amongst the best in the industry. YB outperforms 99.32% of its industry peers.
  • With an excellent Operating Margin value of 30.12%, YB belongs to the best of the industry, outperforming 91.89% of the companies in the same industry.
Industry RankSector Rank
OM 30.12%
PM (TTM) 45.67%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
YB Yearly Profit, Operating, Gross MarginsYB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20

9

2. YB Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so YB is creating value.
  • The number of shares outstanding for YB remains at a similar level compared to 1 year ago.
  • There is no outstanding debt for YB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
YB Yearly Shares OutstandingYB Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M 40M
YB Yearly Total Debt VS Total AssetsYB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 5.22 indicates that YB is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 5.22, YB belongs to the top of the industry, outperforming 97.97% of the companies in the same industry.
  • YB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.22
ROIC/WACC4.22
WACC7.54%
YB Yearly LT Debt VS Equity VS FCFYB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 3.40 indicates that YB has no problem at all paying its short term obligations.
  • YB has a better Current ratio (3.40) than 93.24% of its industry peers.
  • A Quick Ratio of 3.40 indicates that YB has no problem at all paying its short term obligations.
  • YB's Quick ratio of 3.40 is amongst the best of the industry. YB outperforms 93.24% of its industry peers.
Industry RankSector Rank
Current Ratio 3.4
Quick Ratio 3.4
YB Yearly Current Assets VS Current LiabilitesYB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2

3. YB Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 231.74% over the past year.
  • YB shows a strong growth in Revenue. In the last year, the Revenue has grown by 60.60%.
EPS 1Y (TTM)231.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%424.2%
Revenue 1Y (TTM)60.6%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%33.59%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
YB Yearly Revenue VS EstimatesYB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 1B 2B 3B

3

4. YB Valuation Analysis

4.1 Price/Earnings Ratio

  • YB is valuated cheaply with a Price/Earnings ratio of 2.68.
  • Based on the Price/Earnings ratio, YB is valued cheaper than 86.49% of the companies in the same industry.
  • YB's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.88.
Industry RankSector Rank
PE 2.68
Fwd PE N/A
YB Price Earnings VS Forward Price EarningsYB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -1.2
YB Per share dataYB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The decent profitability rating of YB may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. YB Dividend Analysis

5.1 Amount

  • No dividends for YB!.
Industry RankSector Rank
Dividend Yield 0%

YB Fundamentals: All Metrics, Ratios and Statistics

YUANBAO INC -ADR

NASDAQ:YB (3/27/2026, 8:00:03 PM)

16.99

-0.32 (-1.85%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)12-03
Earnings (Next)N/A
Inst Owners10.54%
Inst Owner Change-4.59%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap765.91M
Revenue(TTM)4.09B
Net Income(TTM)1.87B
Analysts40
Price TargetN/A
Short Float %1.5%
Short Ratio1.53
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.68
Fwd PE N/A
P/S 1.3
P/FCF N/A
P/OCF N/A
P/B 1.77
P/tB 1.81
EV/EBITDA -1.2
EPS(TTM)6.33
EY37.26%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS13.12
BVpS9.62
TBVpS9.41
PEG (NY)N/A
PEG (5Y)N/A
Graham Number37.01
Profitability
Industry RankSector Rank
ROA 43.78%
ROE 62.3%
ROCE 40.24%
ROIC 31.79%
ROICexc N/A
ROICexgc N/A
OM 30.12%
PM (TTM) 45.67%
GM N/A
FCFM N/A
ROA(3y)-15.55%
ROA(5y)N/A
ROE(3y)-30.13%
ROE(5y)N/A
ROIC(3y)17.77%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)22.5%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.4
Quick Ratio 3.4
Altman-Z 5.22
F-ScoreN/A
WACC7.54%
ROIC/WACC4.22
Cap/Depr(3y)24.38%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.2%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)231.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%424.2%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)60.6%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%33.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y389.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y175.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y173.23%
OCF growth 3YN/A
OCF growth 5YN/A

YUANBAO INC -ADR / YB Fundamental Analysis FAQ

What is the fundamental rating for YB stock?

ChartMill assigns a fundamental rating of 5 / 10 to YB.


What is the valuation status for YB stock?

ChartMill assigns a valuation rating of 3 / 10 to YUANBAO INC -ADR (YB). This can be considered as Overvalued.


What is the profitability of YB stock?

YUANBAO INC -ADR (YB) has a profitability rating of 6 / 10.


What is the financial health of YUANBAO INC -ADR (YB) stock?

The financial health rating of YUANBAO INC -ADR (YB) is 9 / 10.